Key Takeaways
- • Balyasny Asset Management disclosed a 3.4 million share position in SpaceX, valued at approximately $459 million at the IPO price of $135 per share, representing roughly 0.6% of the hedge fund's $77 billion in assets under management.
- • SpaceX completed its IPO on June 12, 2026, on the Nasdaq under ticker SPCX at $135 per share, with the stock surging nearly 20% on debut before reaching a peak of approximately $226 and subsequently entering a volatile trading pattern.
- • Balyasny's disclosure does not specify acquisition timing or cost basis, leaving unclear whether shares were purchased at the IPO price or in secondary market trading, or what the fund's current profit or loss position may be.
- • An insider lockup expiration scheduled for early August 2026 will release approximately 911.5 million shares held by employees, early investors, and insiders for potential sale on the open market, creating significant supply-side pressure.
- • Balyasny's substantial balance sheet positions the firm to absorb potential short-term market drawdowns triggered by lockup expiration, contrasting with smaller market participants that may be forced to liquidate positions.
Summary
Balyasny Asset Management, the Chicago-based multi-strategy hedge fund with approximately $77 billion in assets under management, has disclosed ownership of 3.4 million shares in SpaceX following the company's landmark initial public offering. The position, disclosed via 13F filing, represents a $459 million allocation at SpaceX's IPO price of $135 per share, constituting approximately 0.6% of the fund's total assets under management as of Q1 2026.
SpaceX went public on the Nasdaq on June 12, 2026, under the ticker symbol SPCX, pricing at $135 per share. The stock demonstrated significant volatility in its immediate post-IPO period, surging nearly 20% on its opening day before climbing to approximately $226 per share. The stock subsequently entered a more volatile trading pattern, with prices subsequently declining below the IPO launch price.
The timing of Balyasny's disclosure is notable given the imminence of a critical market catalyst: an insider lockup expiration scheduled for early August 2026. This lockup release is expected to unlock approximately 911.5 million shares held by SpaceX employees, early investors, and company insiders, making them eligible for sale on the open market for the first time since the IPO. Such lockup expirations typically create significant selling pressure and stock price volatility, as large tranches of restricted shares suddenly become available for liquidation.
Balyasny's filing does not specify when the fund acquired its shares—whether at the IPO price or in secondary market trading after the stock's debut—nor does it disclose the position's cost basis. This information gap means the fund's profit or loss position on the trade remains opaque to the market. However, Balyasny's substantial $77 billion asset base positions the firm to absorb potential short-term drawdowns that would prove problematic for smaller institutional investors, providing a structural advantage as the lockup expiration approaches and heightened selling pressure materializes.
SpaceX went public on the Nasdaq on June 12, 2026, under the ticker symbol SPCX, pricing at $135 per share. The stock demonstrated significant volatility in its immediate post-IPO period, surging nearly 20% on its opening day before climbing to approximately $226 per share. The stock subsequently entered a more volatile trading pattern, with prices subsequently declining below the IPO launch price.
The timing of Balyasny's disclosure is notable given the imminence of a critical market catalyst: an insider lockup expiration scheduled for early August 2026. This lockup release is expected to unlock approximately 911.5 million shares held by SpaceX employees, early investors, and company insiders, making them eligible for sale on the open market for the first time since the IPO. Such lockup expirations typically create significant selling pressure and stock price volatility, as large tranches of restricted shares suddenly become available for liquidation.
Balyasny's filing does not specify when the fund acquired its shares—whether at the IPO price or in secondary market trading after the stock's debut—nor does it disclose the position's cost basis. This information gap means the fund's profit or loss position on the trade remains opaque to the market. However, Balyasny's substantial $77 billion asset base positions the firm to absorb potential short-term drawdowns that would prove problematic for smaller institutional investors, providing a structural advantage as the lockup expiration approaches and heightened selling pressure materializes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.